TrialRadiation oncology (London, England)2020

Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial.

Jin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.